News
Category
BioEleSonic Attends Latest MedTech Conferences
This past week was a great success for our subsidiary company, BioEleSonic, where they had the pleasure of attending MEDICA – ...
Read More
SynDermix Announces Interim Changes to Leadership
Delegate of the Board and Chief Executive Officer of SynDermix AG, Mr. Dieter Hemmer, on medical leave of absence; Dr. ...
Read More
Update on the Clinical Trial of the SDX-3101 Medical Device
SynDermix AG announced temporary postponement of initiation of the SDX-3101 clinical trial on chronic rhinosinusitis without nasal polyps due to ...
Read More
First Site Initiation Visit (SIV) Completed for the Clinical Trial of SDX-3101 in Austria
SynDermix AG is pleased to announce the successful completion of the first SIV for the clinical trial of SDX-3101, in ...
Read More
Collaboration with King’s College London on the Formulation Development of SDX-21
SynDermix AG is proud to announce its collaboration with King’s College London for the development of its Nitric Oxide technology. ...
Read More
AGM 2019: Re-election of Chairman and Board of Directors
Shareholders approve all proposals put forward by the Board of Directors and re-elect the Chairman and Directors to the board ...
Read More
SynDermix to Sell Majority Stake of SDX-Cosmetics
SynDermix announces the sale of a majority stake of SDX Cosmetics – formerly a fully owned subsidiary of SynDermix AG. ...
Read More
SynDermix Announces Changes to the Executive Team
The Board of SynDermix announces changes in the management and executive team. ZURICH, SWITZERLAND – 1 April, 2019 The ...
Read More
Share Capital Increased
The Board of Directors announces a successful increase of share capital: A total of CHF 1 000 000 in loans ...
Read More
CHF 10 Million Investment
The Board of SynDermix is pleased to announce the closure of a new investment of CHF 10 million in the ...
Read More